Sachetta’s AbbVie ABBV Stock Holding History

Sachetta’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$273K	Buy	1,086 +127	+13%	+$27.3K	0.13%	81
2026 Q1	$208K	Sell	959 -129	-12%	-$28.6K	0.11%	93
2025 Q4	$249K	Sell	1,088 -4,027	-79%	-$917K	0.14%	83
2025 Q3	$1.18M	Buy	5,115 +11	+0.2%	+$2.24K	0.44%	44
2025 Q2	$947K	Sell	5,104 -339	-6%	-$63K	0.37%	54
2025 Q1	$1.14M	Sell	5,443 -110	-2%	-$21.4K	0.47%	47
2024 Q4	$987K	Sell	5,553 -235	-4%	-$43.2K	0.39%	57
2024 Q3	$1.14M	Buy	5,788 +201	+4%	+$37.5K	0.45%	50
2024 Q2	$1.04M	Buy	5,587 +320	+6%	+$53K	0.45%	47
2024 Q1	$816K	Hold	5,267	–	–	0.39%	53
2023 Q4	$816K	Buy	+5,267	New	+$768K	0.39%	53

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Sachetta's ABBV Position: Q2 2026 in Review

Sachetta increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $27.3K and bringing the position to 1,086 shares worth $273K. The position accounts for 0.13% of the portfolio, ranked #81.

Sachetta first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.18M in Q3 2025. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sachetta held 1,086 shares of AbbVie worth $273K as of Q2 2026.
Sachetta bought 127 AbbVie shares in Q2 2026, an estimated $27.3K.
AbbVie made up 0.13% of Sachetta's portfolio in Q2 2026, its #81 holding.
Sachetta first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Sachetta's AbbVie position peaked at $1.18M in Q3 2025.
921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.